DE MARIA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 30.888
AS - Asia 3.183
NA - Nord America 2.320
SA - Sud America 270
Continente sconosciuto - Info sul continente non disponibili 250
AF - Africa 59
OC - Oceania 5
Totale 36.975
Nazione #
IT - Italia 30.362
US - Stati Uniti d'America 2.152
SG - Singapore 1.368
CN - Cina 792
VN - Vietnam 529
FR - Francia 257
BD - Bangladesh 204
BR - Brasile 170
HK - Hong Kong 110
CA - Canada 65
FI - Finlandia 65
DE - Germania 62
AR - Argentina 48
MX - Messico 41
JP - Giappone 31
CH - Svizzera 23
GB - Regno Unito 23
IN - India 21
ID - Indonesia 19
IQ - Iraq 18
JM - Giamaica 17
NL - Olanda 16
ZA - Sudafrica 16
EC - Ecuador 13
ES - Italia 13
PH - Filippine 13
CO - Colombia 11
HN - Honduras 11
TW - Taiwan 11
KR - Corea 10
KE - Kenya 9
VE - Venezuela 9
PK - Pakistan 8
SA - Arabia Saudita 8
PY - Paraguay 7
TR - Turchia 7
DZ - Algeria 6
GT - Guatemala 6
IE - Irlanda 6
MA - Marocco 6
PL - Polonia 6
RU - Federazione Russa 6
TN - Tunisia 6
AT - Austria 5
AU - Australia 5
CL - Cile 5
MY - Malesia 5
UZ - Uzbekistan 5
HU - Ungheria 4
JO - Giordania 4
NI - Nicaragua 4
PT - Portogallo 4
RS - Serbia 4
SV - El Salvador 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BB - Barbados 3
BE - Belgio 3
CR - Costa Rica 3
EG - Egitto 3
KZ - Kazakistan 3
NP - Nepal 3
PR - Porto Rico 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
IL - Israele 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SI - Slovenia 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
MF - Saint Martin 1
MM - Myanmar 1
MN - Mongolia 1
Totale 36.718
Città #
Genova 18.092
Genoa 7.383
Rapallo 2.776
Vado Ligure 1.777
Singapore 650
San Jose 601
Lauterbourg 243
Ashburn 188
Ho Chi Minh City 162
New York 117
Beijing 110
Hanoi 105
Hong Kong 103
Helsinki 63
Council Bluffs 61
Bordighera 50
Milan 48
Frankfurt am Main 47
Santa Clara 42
Los Angeles 38
Tokyo 28
Chicago 27
Rome 27
Mexico City 26
Atlanta 23
Buffalo 23
Haiphong 23
Zurich 23
Da Nang 21
Dallas 18
Tianjin 18
Orem 14
Las Vegas 13
São Paulo 13
Biên Hòa 12
Charlotte 12
City of London 12
Houston 12
Phoenix 12
San Francisco 12
Amsterdam 11
Naples 11
Guangzhou 10
Miami 10
Philadelphia 10
Washington 10
Florence 9
Kingston 9
Montreal 9
Toronto 9
Des Moines 8
Jacksonville 8
Queens 8
Turin 8
Hải Dương 7
Manlius 7
Nairobi 7
San Antonio 7
Shanghai 7
Baghdad 6
Bari 6
Buenos Aires 6
Dublin 6
Figino 6
Johannesburg 6
Kansas City 6
Louisville 6
Nuremberg 6
Palermo 6
Phủ Lý 6
Princeton 6
Springfield 6
Brooklyn 5
Bắc Ninh 5
Cape Town 5
Curitiba 5
Dammam 5
Dhaka 5
Fort Wayne 5
Madrid 5
Newark 5
Padua 5
Rio de Janeiro 5
Sydney 5
Tegucigalpa 5
The Bronx 5
Thái Nguyên 5
Alexandria 4
Amman 4
Anaheim 4
Billings 4
Boardman 4
Campinas 4
Cleveland 4
Fayetteville 4
Fresno 4
Garland 4
Guatemala City 4
Hewitt 4
Knoxville 4
Totale 33.395
Nome #
A modular framework for the development of targeted Covid-19 blood transcript profiling panels 347
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 344
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 249
Evaluation of Frequency of CMV Replication and Disease Complications Reveals New Cellular Defects and a Time Dependent Pattern in CVID Patients 230
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 219
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 208
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 206
Analysis of clinical management of infected breast implants and of factors associated to successful breast pocket salvage in infections occurring after breast reconstruction 206
Il sistema TIDA nell'emicrania: effetto della nomifensina sulla secrezione di prolattina 200
Use of maraviroc in clinical practice: a multicenter observational study 198
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 196
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 195
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 194
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 193
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 191
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 190
Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients. 188
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 187
Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception 185
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. 184
Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine reverse transcription inhibitor backbone 182
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. 182
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. 182
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 182
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection 181
Are there Gender and Race Differences in cellular immunity patterns over age in infected and uninfected children born to HIV-1 infected women? 180
HCV-related polyradiculoneuropathy in a HIV-positive man 180
Bloodstream infections in critically ill patients with COVID-19 180
Analysis of NK cell function and receptor expression during HTLV-1 and HTLV-2 infection 178
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 177
Adhesion of human neuroblasts to HIV-1 tat. 175
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 174
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study 173
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 173
Early versus late treatment with Zidovudine 172
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 172
Empirical first-line treatment with tigecycline for febrile episodes following abdominal surgery in cancer patients 171
Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to- child transmission of HIV in Europe 171
Absence of HIV-1 after treatment cessation in an infant. 170
Use of Neonatal Antiretroviral Prophylaxis for Prevention of Mother‐to‐Child Transmission of HIV Is Decreasing in Western Europe 168
Popolazione di precursori linfoidi umani, metodo per la loro identificazione e relativi usi 168
Breast implant infection due to Paenibacillus residui in a cancer patient 167
Clinical and Microbiological Characterization of Late Breast Implant Infections after Reconstructive Breast Cancer Surgery 167
Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation. 166
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients 165
HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status. 164
Are girls more at risk of intrauterine-acquired HIV infection than boys? 163
Accuracy of HCV-RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infection. 163
Human NK Cells and Herpesviruses: Mechanisms of Recognition, Response and Adaptation 163
Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women? 162
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication. 159
Breast Implant Infections after Surgical Reconstruction in Patients with Breast Cancer: Assessment of Risk Factors and Pathogens over Extended Post-Operative Observation. 159
Effects on growth after switching protease inhibitors to efavirenz in HIV-1-infected children 158
Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV. 158
Clinically stable treatment-experienced adults receiving tenofovir and didanosine. 156
Unsung hero Robert C. Gallo 156
Children born to women with HIV-1 infection: natural history and risk of transmission 154
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 154
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 153
Late symptomatic neurosyphilis presenting as a motor polyradiculoneuropathy. 153
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 153
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 153
Age-related standards for T-lymphocye subsets based on uninfected children born to human immunodeficiency virus 1-infected women 152
Unusual presentation of visceral leishmaniasis in an HIV-infected patient. 152
Inherent transcriptional signatures of NK cells are associated with response to IFNΑ+rivabirin therapy in patients with Hepatitis C Virus 152
Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. 152
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 152
HLA-class I-specific inhibitory receptors in HIV-1 infection. 151
NK cell receptors and their interactions with MHC. 151
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. 151
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. 151
Age-related lymphocyte and neutrophil levels in children of hepatitis C-infected women 150
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1 infected patients 149
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 149
Receptor modulation and functional activation of human CD34(+) Lin(-) -derived immature NK-cells in vitro by Mycobacterium Bovis Calmette-Guerin (BCG). 148
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 148
A mature NK profile at the time of HIV primary infection is associated with an early response to cART 147
Involvement of activating NK cell receptors and their modulation in pathogen immunity. 146
Improvements in virological control among women conceiving on combination antiretroviral therapy in Western Europe. 146
Detection of CD8 T-cell expansions with restricted T-cell receptor V gene usage in infants vertically infected by HIV-1. 146
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 146
HIV serological screening in a population of pregnant women in the Republic of Congo: suitability of different assays 145
Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers. 145
Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. 145
Immunology of tuberculosis. 144
Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy. 144
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients 144
Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man. 142
Perinatal findings in children born to HIV-infected mothers 142
Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells. 142
Pre-filled normal saline syringes to reduce totally implantable venous access device-associated bloodstream infection: a single institution pilot study. 142
Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients 142
Levels and patterns of HIV RNA viral load in untreated pregnant women. 142
Detection of virus in vertically exposed HIV-antibody-negative children. 141
Management of fever in children: summary of the Italian Pediatric Society guidelines. 141
Weight, height and human immunodeficiency virus infection in young children of infected mothers 141
Role of NK cells in immunotherapy and virotherapy of solid tumors 141
Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. 140
NK cell function in HIV-1 infection 140
Natural killer cell development and maturation revisited: Possible implications of a novel distinct Lin-CD34+DNAM-1brightCXCR4+ cell progenitor 140
Totale 16.889
Categoria #
all - tutte 116.594
article - articoli 105.245
book - libri 349
conference - conferenze 1.753
curatela - curatele 0
other - altro 0
patent - brevetti 1.245
selected - selezionate 0
volume - volumi 8.002
Totale 233.188


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.077 75 185 200 365 154 281 161 736 136 316 80 388
2022/20233.365 340 203 44 311 487 648 56 236 537 104 345 54
2023/20241.488 80 252 37 149 123 236 51 117 100 51 97 195
2024/20254.768 144 373 135 239 627 473 397 767 204 244 427 738
2025/20268.268 947 250 727 676 1.005 805 1.269 375 558 755 387 514
2026/2027810 810 0 0 0 0 0 0 0 0 0 0 0
Totale 36.975